HHS Logo U.S. Department of Health & Human Services Divider arrowNIH logo National Institutes of Health Alt desc
Skip Over Navigation Links
Doctor and patient in exam room

CTSA Program Trial Innovation Network

Through NCATS’ new Trial Innovation Network, CTSA Program-supported investigators are working collaboratively to tackle inefficiencies in clinical trials.

Cell biologist Shawn Hingtgen, Ph.D., in his lab

CTSA Program Mentoring Paves Way for Brain Cancer Therapy

Mentoring support through NCATS’ Clinical and Translational Science Awards Program sparked a research team that developed a potential therapy for brain cancer.

Female reproductive system on a chip.

Research Team Advances Evatar Female Reproductive System

Through its Tissue Chip for Drug Screening program, NCATS supports research to mimic a woman’s body in processes such as the 28-day reproductive cycle.

The cyclic peptide ipglycermide (iPGM) binds to an iPGM enzyme, blocking the enzyme’s activity

Scientists Advance Parasite and Bacteria Research

NCATS and University of Tokyo scientists have identified the first inhibitor of an enzyme thought to be a potential drug target for fighting disease-causing parasites and bacteria.

NCATS e-newsletter displayed on a tablet

April E-Newsletter Now Available

Read about NCATS’ Trial Innovation Network and career mentoring via its CTSA Program, a potential approach against parasites, and more.

April E-Newsletter Now Available

Read about NCATS’ Trial Innovation Network and career mentoring via its CTSA Program, a potential approach against parasites, and more.

NCATS e-newsletter displayed on a tablet

CTSA Program Trial Innovation Network

Through NCATS’ new Trial Innovation Network, CTSA Program-supported investigators are working collaboratively to tackle inefficiencies in clinical trials.

Doctor and patient in exam room

CTSA Program Mentoring Paves Way for Brain Cancer Therapy

Mentoring support through NCATS’ Clinical and Translational Science Awards Program sparked a research team that developed a potential therapy for brain cancer.

Cell biologist Shawn Hingtgen, Ph.D., in his lab

Scientists Advance Parasite and Bacteria Research

NCATS and University of Tokyo scientists have identified the first inhibitor of an enzyme thought to be a potential drug target for fighting disease-causing parasites and bacteria.

The cyclic peptide ipglycermide (iPGM) binds to an iPGM enzyme, blocking the enzyme’s activity

Research Team Advances Evatar Female Reproductive System

Through its Tissue Chip for Drug Screening program, NCATS supports research to mimic a woman’s body in processes such as the 28-day reproductive cycle.

Female reproductive system on a chip.

More Center News

Niemann-Pick type C1 project team
NPC1 Research Advances

Collaboration enabled advance of potential treatment.

Assay Guidance Manual Updates

Two new chapters added to the best practices guide.

  • Facebook icon
  • Twitter icon
  • YouTube icon

View Rare Disease Patient Videos

Alani, a girl who has congenital generalized lipodystrophy

Watch rare disease patients and caregivers talk about the challenges they face and how NIH’s collaborative research efforts offer hope. View the videos.

Work with Us

Learn more about all the ways that potential grantees, partners and collaborators can access NCATS support to advance translational science.

  • NCATS Programs & Initiatives
    NCATS encourages partnerships that cross many scientific disciplines and research sectors in pursuit of translational success.
  • Small Business Opportunities
    NCATS’ small business programs help entrepreneurs develop and commercialize new translational technologies.
  • Expertise & Resources
    NCATS staff are experts in translation, and the Center’s resources support pre-clinical and clinical activities.
  • Licensing Opportunities
    NCATS makes it easy for industry and academia to interact and partner with Center laboratories and scientists.